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HSAF-induced antifungal effects in Candida
albicans through ROS-mediated apoptosis
Yanjiao Ding,a Zhenyu Li,a Yaoyao Li,a Chunhua Lu,a Haoxin Wang,b Yuemao Shen*ab
and Liangcheng Du*c
Heat-stable antifungal factor (HSAF) belongs to polycyclic tetramate macrolactams (PTMs), which inhibits
many fungal pathogens and is effective in inhibiting Candida albicans (C. albicans). In this study, we
found that HSAF induced the apoptosis of C. albicans SC5314 through inducing the production of
reactive oxygen species (ROS). Nevertheless, we validated the efficacy of HSAF against candidiasis
caused by C. albicans in a murine model in vivo, and HSAF significantly improved survival and reduced
fungal burden compared to vehicles. A molecular dynamics (MD) simulation was also investigated,
revealing the theoretical binding mode of HSAF to the b-tubulin of C. albicans. This study first found
PTMs-induced fungal apoptosis through ROS accumulation in C. albicans and its potential as a novel
agent for fungicides.
Introduction
In recent decades, the incidence and frequency of invasive fungal
infections have been widespread and there has been a sharpened
increase inmortality due tomycoses, especially in the population
of immuncompromised patients. Fungal infections are a major
source of global morbidity and mortality, especially for the
species of Candida and Aspergillus.1 Therefore, how to treat the C.
albicans infection has attracted the interest of the worldwide
researchers. At present, the most common antifungal drugs are
the azoles such as imidazoles, triazoles, voriconazole and pos-
aconazole, which disrupt the cell membrane by inhibiting the
biosynthesis of ergosterol.2 The polyenes such as nystatin and
amphotericin B bind ergosterol and destroy the fungal cell
membrane. Echinocandis such as caspofungin, micafungin and
anidulafungin inhibit the synthesis of fungal wall by blockage of
the glucan synthase.3 However, Candida species has been re-
ported to show azole resistances through upregulation of efflux,
mutation and overexpression to confront the variety of stress
conditions.4,5 New anti-Candida drugs with distinct chemical
structures and mechanism of action are urgently required.
Heat-stable antifungal factor (HSAF) was isolated from
Lyaobacter enzymogenes C3, a biocontrol strain for many fungal
plant diseases6 and belongs to polycyclic tetramate macro-
lactam (PTM), which is a tetramic acid (2,4-pyrrolidinedione)-
containing macrolactam.7 PTMs as a new emerging class of
natural products have shown signicant bioactivities, including
antifungal, antibiotic, and antitumor properties.8 Previously, Li
and coworkers showed that HSAF induced aberrant deposition
of thick cell wall patches to inhibit the growth of Aspergillus
nidulans, and proposed that the antifungal activity of HSAF was
mediated by disrupting the biosynthesis of ceramide.9 Though
great efforts have been made to investigate the mode of action
of HSAF, the cellular biological mechanisms and the target of
HSAF are still unknown. Ceramides have been reported to have
effects on mitochondria including enhanced generation of
reactive oxygen species (ROS).10 Recent studies have reported
that major classes of antibiotics contribute to induce apoptosis
via the production of ROS.11 Therefore, to determine whether or
not HSAF induced apoptosis in C. albicans through ROS accu-
mulation, we investigated various apoptotic features aer
treatment with HSAF. In this study, we reported the antifungal
activity of HSAF against lamentous pathogenic fungi, yeast
and lamentous forms of C. albicans in vitro. Nevertheless, we
validated the efficacy of HSAF against candidiasis caused by C.
albicans in mice model in vivo. We investigated the antifungal
mechanism of HSAF using RNA-seq technology, morphological,
and molecular assays to conrm its mode of action and found
that HSAF exhibited potent anti-Candida activity, arresting cells
at G2/M phase and triggering apoptosis via an ROS dependent
pathway.
Experimental section
Fungal strains and growth conditions
The lamentous pathogenic fungi were maintained on potato
dextrose agar (PDA) medium including 20% potato, 2%
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dextrose and 2% agar at 25 C for 5 d. C. albicans (ATCC 5314)
was used for all experiments described and was cultured in YPD
medium containing 1% yeast extract, 2% peptone, and 2%
dextrose with 250 rpm at 28 C, overnight. C. albicans cultures
were grown to an optical density 600 of 0.1 to 1.0 and diluted,
coated plates, counted to determine the relationship between
OD600 and log CFU mL
1. C. albicans cultures were diluted into
the YPD and grown to an optical density 600 of 0.2, at which
point the HSAF were added. The Minimum Inhibitory
Concentrations (MICs) were determined using the Clinical and
Laboratory Standards Institute (CLSI) method.12
Total RNA extraction and high throughput sequencing
Total RNA (10 mg) was extracted using fungal RNA kit (OMEGA
BIO-TBK) according to the manufacturer's instructions. The
RNA quality and quantity were assessed using a NanoDrop-
Spectrophotometer ND-1000 (NanoDrop Technologies, Wil-
mington, DE, USA). A260/280 ratio (approx. 1.8–2.0) for RNA
samples calculated by Nanodrop was also considered to check
quality of the RNA preparation. RNA-seq libraries were prepared
and sequenced by Macrogen, Inc. (South Korea) with the Illu-
mina HiSeq 2000 technology. To study the global effect of HSAF,
cells were exposed to HSAF concentration (10 mg mL1) over
10 h. Whole-cell RNA was sequenced for both control- and
HSAF-exposed cells with 30 million 50-bp paired-end reads
generated per sample.
Assay for germ tube formation
A colony of C. albicans SC5314 was used to inoculate 2 mL of
YPD medium. The cells were incubated for at least 48 h at 25 C
without shaking and then centrifuged for 5 min at 2000g to
pellet the cells. The pellet was then resuspended with RPMI
1640. The cells of C. albicans were diluted to OD600 ¼ 0.2 and
dispensed into a 96-well at-bottom polystyrene plate. Samples
were treated with 1.5, 3 and 6 mg mL1 HSAF with dimethyl
sulfoxide (DMSO) at a nal concentration of 1%. The plate was
placed in a 37 C incubator for 4 h without shaking.13 Germ tube
attached to the wells were stained with 100 mL of 0.02% crystal
violet dissolved in phosphate–buffered saline (PBS) for 15 min
and then analyzed by ZEISS uorescence microscope (ZEISS,
Axio Observer A1, Germany) using a 40 objective.
Measurement of ROS production in C. albicans
C. albicans cells were treated with HSAF using 20,70-dichlor-
uorescin diacetate (DCFH-DA) to measure the endogenous ROS.
Logarithmically growing C. albicans cells were treated with 3, 6 and
12 mg mL1 HSAF or DMSO in YPD for 1, 2 and 3 h at 28 C, aer
that cells were washedwith PBS (pH 7.4) three times andDCFH-DA
was added which nal concentration with 10 mM in PBS. Aer 30
min incubation at 28 C, samples were quantitatively analyzed
with a ow cytometer (Becton Dickinson, San Jose, CA, USA).
Measurement of mitochondrial membrane potential (DJm)
DiOC6(3) was used as the marker to measure the effect of HSAF
on the mitochondrial membrane potential of C. albicans. Cells
were harvested and incubated with 3, 6 and 12 mg mL1 HSAF or
DMSO for 3 h at 28 C. Aer that, cells were washed with PBS
(pH 7.4) three times and incubated with 100 nM DiOC6(3) for 30
min. Samples were analyzed by ow cytometer (Becton Dick-
inson, San Jose, CA, USA) as previously described.14
Cell cycle analysis by ow cytometry
The DNA content was quantied by the ow cytometry of the
cells stained with the DNA-specic uorescent dye propidium
iodide (PI). The exponential phased cells of C. albicans were
grown in YPD medium and then harvested and treated with 3, 6
and 12 mg mL1 HSAF, meanwhile adding 1 mM and 5 mM
ascorbic acid (AA) for 30 min prior to the addition of 12 mg mL1
HSAF. Aer incubation for 3 h, the cells were washed with PBS
three times and xed with 70% ethanol overnight at 20 C.
The cells were treated with 100 mg mL1 RNase A for 2 h at 37 C
and added 50 mg mL1 PI for 1 h at 4 C in the dark. The
samples were analyzed in a FACScan ow cytometer (Becton
Dickinson, San Jose, CA, USA). The values represented the
average of the measurements conducted in triplicate for three
independent assays.
Analysis of early and late apoptotic markers
C. albicans cells were digested with lywallzyme and lysis enzyme
for 2 h at 28 C. Protoplasts were incubated with 3, 6, 12 and 24
mg mL1 HSAF or DMSO for 4, 8 h at 28 C, meanwhile adding 1
mM and 5 mM ascorbic acid (AA) for 30 min prior to the
addition of 24 mg mL1 HSAF. Subsequently, the cells were
washed with PBS (pH 7.4) three times and incubated with 5 mL
FITC-Annexin Ⅴ and 5 mL PI for 20 min in the dark. Meanwhile,
10 mg mL1 amphotericin B (AMB) was as positive control. Aer
that, cells were washed with PBS (pH 7.4) three times and
observed by uorescence microscope (OLYMPUS, IX71, Japan)
using a 63 objective.
DNA fragmentation was analyzed by the terminal deoxy-
nucleotidyl transferase dUTP nick-end labeling method.15
Samples were treated with 3, 6, 12 and 24 mg mL1 HSAF for 4 or
8 h, meanwhile adding 1 mM and 5 mM ascorbic acid (AA) for
30 min prior to the addition of 24 mg mL1 HSAF and then
washed with PBS three times, permeabilized in a permeabiliza-
tion buffer (0.1% sodium citrate and 0.1% Triton X-100) on ice
for 10 min and washed again with PBS three times. DNA ends
were labeled with an in situ cell death detection kit at 37 C for 1
h. Nuclear condensation was analyzed by DAPI staining16 and
then analyzed by uorescence microscope (OLYMPUS, IX71,
Japan) using a 63 objective.
Polymerization assay
The ability of tubulin to polymerize into microtubules can be
followed by observing an increase in optical density of a tubulin
solution at OD340. Tubulin protein from porcine brain was
reconstituted to 5 mg mL1 with cold tubulin buffer (80 mM
PIPES, pH 6.9, 2 mM MgCl2, 0.5 mM EGTA). The tubulin solu-
tion (at 4 C), which was plus 5% glycerol and 1mMGTP adding
10 mM HSAF or 10 mM vincristine (vin), was transferred into
a microtiter plate, which had been pre-warmed to 37 C.
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Tubulin polymerization was measured by taking readings every
30 s for 30 min. Absorbance at 340 mm was monitored in the
spectrophotometer.
Molecular modeling studies
All the molecular modeling were performed on a Dell Precision
T5500 workstation. The molecular docking was conducted
using SYBYL-X 1.1 (Tripos, St. Louis, MO, USA). The wild type
and mutant strains of C. albicans b-tubulin proteins were built
by SWISS-MODEL, a fully automated protein structure
homology-modelling server.17–20 The compound HSAF was
optimized for 1000-generations until the maximum derivative
of energy became 0.05 kcal (mol1 A˚), using the Tripos force
eld. Charges were computed and added according to Gastei-
gere Hu¨ckel parameters. The optimized HSAF was docked into
the binding site of C. albicans b-tubulin proteins by means of
surex-dock, and the default parameters were used if it was not
mentioned. Then a molecular dynamic (MD) study was per-
formed to revise the docking result.
The Amber 12 and AmberTools 13 programs21 were used for
MD simulations of the selected docked pose. Compound HSAF
was rst prepared by ACPYPE,22 a tool based on ANTE-
CHAMBER for generating automatic topologies and parameters
in different formats for different molecular mechanics
programs, including calculation of partial charges. Then, the
forceeld “leaprc.gaff” (generalized amber forceeld) was used
to prepare the ligand, while “leaprc.ff12SB” was used for the
receptor. The system was placed in a rectangular box (with
a 10.0 A˚ boundary) of TIP3P water using the “SolvateOct”
command with the minimum distance between any solute
atoms. Equilibration of the solvated complex was done by
carrying out a short minimization (1000 steps of each steepest
descent and conjugate gradient method), 500 ps of heating, and
200 ps of density equilibration with weak restraints using the
GPU (NVIDIA® Tesla K20c) accelerated PMEMD (Particle Mesh
Ewald Molecular Dynamics) module. At last, 20 ns of MD
simulations were carried out.
In vivo assay for antifungal activity
To evaluate the effect of HSAF on C. albicans in vivo, a total of
y male BALB/c mice (6–8 weeks old) were obtained from the
Experimental Animal Center of Shandong University (Jinan,
Shandong, China). Animals were maintained in accordance
with the criteria of the Guide for the Care and Use of Laboratory
Animals and approved by the Animal Care and Use Committee
of Shandong University. All efforts were made to minimize the
number of animals used and their suffering.
The animals were housed in cages of ten mice each. C.
albicans was grown at 37 C in YPD medium containing peni-
cillin and streptomycin. Cells were centrifuged, washed in PBS.
Disseminated infection was produced by lateral tail vein injec-
tion of 100 mL inoculum containing 1 106 cells of C. albicans 3
h prior to the start of antifungal therapy. HSAF was intraperi-
toneal injection once daily at doses of 5 mg kg1 of body weight.
Fluconazole (FLU) and AMB were injected in the same way as
the positive control or the same volume of solvent as negative
control. Aer 3 d of therapy, mice were euthanized, kidneys
were immediately removed and weighed and homogenized in
sterile PBS (containing penicillin and streptomycin) and were
serially diluted 1 : 10. Aliquots were plated onto YPD, and
following 24 h of incubation at 37 C, fungal burden (CFU g1)
was determined. The other halves of the kidneys were xed in
10% neutral formalin solution, embedded in paraffin, and
stained with periodic acid–schiff stain and hematoxylin–eosin
stains. In the survival arm, mice were monitored off therapy
until 30 d.
Results
Antifungal activities of HSAF in vitro
HSAF (Fig. 1A) exhibited antifungal activity against broad range
of plant pathogenic fungi, including P. grisea, F. verticillioide, R.
solani, and S. sclerotiorum (Fig. 1B). The MIC value of HSAF
against C. albicans was 24 mg mL1. C. albicans is a dimorphic
fungus, which changes from yeast to hyphal form. The yeast-to-
hyphal transition starts with the formation of a germ tube,
which is suggested as a potential virulence factor in their
pathogenesis.23 HSAF displayed evident inhibitory effect on the
germ tube formation of C. albicans at the concentration of 6 mg
mL1 in comparison to vehicle (Fig. 1C). These results indicated
that HSAF not only inhibited yeast cell growth, but also
inhibited the germ tube formation of C. albicans.
Gene annotation and functional classication
RNA sequencing was used to determine differential gene
expression in response to treatment with a low dose of HSAF.
The RNA-seq analysis revealed many genes are up-regulated or
down-regulated in response to HSAF (Fig. 2A). The international
standardized gene functional classication system Gene
Ontology (GO) provided three ontologies including biological
processes, cellular components and molecular functions
(Fig. 2B), which were useful for gene annotation and analysis.24
Two-group comparison showed differential expression of
a number of transcripts. Gene ontology analysis revealed
signicant variation inmany differentially expressed transcripts
across comparisons. In comparison to vehicle, maximum
number of transcripts were related to cellular component (n ¼
1107), the number of transcripts involved in biological
processes was also high (n ¼ 1069). The heat maps showed the
metabolic bases of the interaction between the cells treated with
DMSO and HSAF. Among the differentially expressed genes
identied, a suite of genes involved in carbohydrate metabolism
and cell cycle were found to be up-regulated under HSAF, con-
rming the signicance of this compound in the ROS pathway
(Fig. 2C).
RNA-seq technology provided a useful tool for transcriptome
analysis and it offered broad and deep insights into gene
regulatory networks and biological pathways.24 Based on tran-
scriptional sequencing and analysis, we rst identied differ-
entially expressed genes (DEGs) between the untreated and
treated cells with HSAF. Moreover, we identied important
regulatory genes involved in the ROS pathway. These results will
This journal is © The Royal Society of Chemistry 2016 RSC Adv., 2016, 6, 30895–30904 | 30897
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Fig. 1 Structure of HSAF (A). Antifungal activities of HSAF. HSAF effected on mycelial growth of fungus at the dose of 0, 5, 10, 15 and 20 mg mL1
in vitro. Photographs indicating Petri dishes containing each fungal species including P. grisea, F. verticillioide, R. solani and S. sclerotiorumwere
taken by digital camera at 5 days after inoculation of conidia (B). HSAF inhibited the tube of C. albicans. Stained by crystal violet and observed
under a fluorescentmicroscope. The cultures were incubated for 48 h in RPMI 1640medium at 25 Cwithout shaking, the cells were treatedwith
DMSO, 1.5, 3 and 6 mg mL1 HSAF at 37 C for 4 h, HSAF inhibited the yeast-to-hyphal transformation at low concentration with 6 mg mL1, scale
bar, 10 mm (C).
Fig. 2 Gene expression differences among the different samples. The correlation scatter plot of gene expression was difference in response to
HSAF at 10 mg mL1 for 10 h (A). Histogram presentation of gene ontology classifications. The results were summarized in three main categories:
biological processes, cellular components, and molecular functions with 10 mg mL1 HSAF treating for 10 h. The x-axis on the right side shows
the number of genes (B). A heat-map showed transcription factor family genes that were differentially expressed protein levels of energy
metabolism, cell growth and death pathway in response to HSAF at 10 mgmL1 for 10 h. The color scale indicates fold-change in gene expression.
Yellow indicates high expression and blue indicates low expression (C).
30898 | RSC Adv., 2016, 6, 30895–30904 This journal is © The Royal Society of Chemistry 2016
RSC Advances Paper
View Article Online
be helpful for elucidating the molecular mechanisms of HSAF
effecting on fungi.
HSAF induced total intracellular ROS levels increasing and
triggered collapse of mitochondrial membrane potential
(DJm)
In order to determine if the mechanism of killing by HSAF was
ROS mediated, we examined ROS levels of C. albicans cells
treated with or without HSAF by uorimetric assay. Generation
of ROS was monitored by incubation of HSAF at 3, 6 and 12 mg
mL1 with the Candida cells for 1, 2, and 3 h, respectively. ROS
levels were slightly elevated in Candida cells aer exposure to
HSAF at low concentrations for 2 h. Moreover, high concen-
tration of HSAF treatment caused a marked ROS increase in
Candida cells aer 2 h (Fig. 3A). These ndings indicated that
HSAF could induce the ROS accumulation in C. albicans cells in
a time- and dose-dependent manner.
Previous study suggested that mitochondrial ROS triggered
cell apoptosis may occur via formation of the mitochondrial
permeability transition pore complex, a crucial step in mito-
chondrial demolition.25 DiOC6(3) is a mitochondrial dye that
aggregates into healthy mitochondria and uoresces green and
it is specically used to determine the decreases in the
membrane potential of mitochondria stimuli.26 Cells of C.
albicans were treated with 3 mg mL1 HSAF resulted in
a decrease in the DJm about 45.03%, while the concentration of
HSAF reached 12 mg mL1, HSAF could induce a signicant
decrease in the DJm about 11.92% compared to the vehicle
(Fig. 3B). The result showed that HSAF effect was related to the
dissipation of DJm.
To determine whether the elevated ROS in Candida cells
contributed to HSAF-induced cell death, the anti-Candida
activity of HSAF without and with the ROS scavengers, ascorbic
acid (AA), acetyl cysteine (NAC), glutathione (GSH) and thiourea
Fig. 3 HSAF-dependent ROS production led to fungal cell death. Histograms showed the fluorescence intensity of incubated with DCFH-DA.
Cells treatedwith 3, 6 and 12 mgmL1 HSAF for 1, 2 and 3 h (A). Changes inmitochondrial membrane potential. Cells were treatedwith DMSO, 3, 6
and 12 mgmL1 HSAF for 3 h. Stained with DiOC6(3) and analyzed by flow cytometry (B). ROS scavenging agents reduces the antifungal activity of
HSAF againstC. albicans. Scavengers diminished the toxicity of HSAF by 4-fold for 0.5mMAA and by 2-fold for 0.5mMNAC andGSH. Log of CFU
mL1 remaining after drug exposure in the presence and absence of 0.5 mM Vc or TU at 12 mg mL1 HSAF (C).
This journal is © The Royal Society of Chemistry 2016 RSC Adv., 2016, 6, 30895–30904 | 30899
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Fig. 4 Cell cycle analysis of C. albicans assayed by flow cytometry. C. albicans cells were treated by a series of concentrations of HSAF in the
presence of AA or not (A). HSAF induced the early and late apoptosis inC. albicans. Cells treatedwith 3, 6, 12 and 24 mgmL1 HSAF at 4, 8 h shown
by FITC-Annexin-V/PI staining and by TUNEL staining (B). Cells treated with DMSO, 10 mgmL1 AMB, 24 mgmL1 HSAF, 24 mgmL1 HSAF + 1 mM
Vc, 24 mg mL1 HSAF + 5 mM Vc shown by FITC-Annexin-V/PI (C), DAPI staining (D) and TUNEL staining (E) and observed under a fluorescent
microscope. Bar, 10 mm.
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(TU) were examined. We found that exposing exponentially
growing C. albicans to 0.5 mM AA or 5 mM TU, the MIC of HSAF
increased to 100 mg mL1 (Fig. 3C) and diminished the toxicity
of HSAF, reducing killing by about 30-fold at 3 h (Fig. 3C).
HSAF induced G2 cell cycle arrest and apoptosis in C. albicans
through inducing the production of reactive oxygen species
To study the effect of HSAF on cell cycle progression, ow
cytometry analysis was performed. We observed that HSAF
treatment led to more cells accumulating in G2/M phase
compared with vehicle cells. The ratio of cells in G2/M phase
following the treatment of 3, 6 and 12 mg mL1 HSAF increased
to 19.02%, 20.26% and 32.69%, compared to 12.56% in vehicle
group aer 3 h culture in a concentration-dependent manner
(Fig. 4A). The G2-M phase delay induced by HSAF could be
recovered by the supplementation of AA. The results indicated
that HSAF treatment induced a signicant arrest in the G2/M
phase of the cell cycle through inducing the production
of ROS.
Upstream cell-cycle regulators are also involved in effector-
triggered programmed cell death (PCD) in cells.27 Thus, the
further investigation for the anti-Candida mechanism of HSAF
was necessary through examining PCD in C. albicans. Apoptosis,
a physiological mode of programmed cell death, is induced by
diversied cellular stimuli and through many signaling path-
ways.28 In the presence of Ca2+, Annexin V-FITC stain, which
binds to phosphatidylserine,29 can examine the early stage
apoptosis. In the course of early apoptosis, phosphatidylserine
can translocate from inner to the outer of membrane.30 The
protoplasts of C. albicans, which treated with 12 and 24 mg mL1
HSAF aer 4 h, displayed an Annexin V(+)/PI() phenotype as an
early marker of apoptosis, whereas this phenomenon was rarely
observed in 3 and 6 mg mL1 HSAF-treated cells for 4 h. Expo-
sure to 3 and 6 mg mL1 HSAF for 8 h caused early apoptosis in
C. albicans (Fig. 4B). This indicated that HSAF induced early
apoptosis in C. albicans in a time- and dose-dependent manner.
A TUNEL assay was performed to investigate nuclear
morphological features of the late stage of apoptosis in C.
albicans.31 The cells of C. albicans treated with 3 mg mL1 HSAF
cannot induce the late apoptosis at 4 h, and the DNA fragments
were observed when the cells treated with 3 mgmL1 HSAF at 8 h
(Fig. 4B). The cells treated with 24 mg mL1 HSAF exhibited
a signicant amount of changed in the nuclear DNA for 4 h,
consistent with the positive control, which treated with 10 mg
mL1 AMB, as assessed by the DNA-binding uorescent dye
DAPI (Fig. 4D). In the DMSO treated population, chromatin
appeared as single round nuclei appearance. The similar results
were obtained by TUNEL assay (Fig. 4E), which is one of the
most reliable ways for the identication of the late stages of
apoptosis in yeast.32 Either at early or late apoptosis stage, when
added with 1 mM AA, the intensity of uorescence changed
weak, the antifungal activity of HSAF decreased, while added
with 5 mM ascorbic acid, HSAF lost the antifungal activity
(Fig. 4C–E). The results suggested that HSAF had a critical effect
on apoptotic cellular changes either early or late apoptosis
through inducing the accumulation of ROS. It was in a nice dose
and time dependent manner.
Fig. 5 Influence of HSAF on purified tubulin polymerization in vitro. The tubulins were incubated at 37 C in the presence of DMSO, 10 mMHSAF
and 10 mM vincristine and microtubule formation was measured by the spectrophotometer. Absorbance at 340 mm was monitored (A). Plot of
RMSD (in a˚ngstrom) for the b-tubulin-HSAF complex during 20 ns MD simulation (B). The detailed interactions between HSAF and b-tubulin of C.
albicans wild type and HSAF selectively occupies the eleven key residues binding site of the b-tubulin wild type (C).
This journal is © The Royal Society of Chemistry 2016 RSC Adv., 2016, 6, 30895–30904 | 30901
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HSAF inhibited the polymerization of b-tubulin
HSAF disrupted mitochondrial membrane potential, arrested
the cell cycle at the G2/M phase, and induced apoptosis,
a hallmark of microtubule destabilizing drugs.33 Moreover,
mitochondria may connect microtubule damage to the
apoptotic machinery, acting as appropriate, and timing
switches for the onset of apoptosis.34 According to these
observations. We tested whether HSAF directly inhibited
tubulin polymerization in vitro. HSAF were assayed for inhibi-
tion of tubulin polymerization in a biochemical assay using
puried tubulin isolated from porcine brain. HSAF strongly
inhibited tubulin polymerization under 340 nm in vitro. A
similar activity was exhibited by vinblastine (Fig. 5A).
To better elucidate the detailed interactions between HSAF
and b-tubulin at the molecular level and to understand the
structural basis of their binding mode, a docking study of HSAF
was rst performed using SYBYL-X 1.1 and then MD simula-
tions were carried out by Amber 12. The b-tubulin-HSAF
complex was equilibrated aer 20 ns MD simulation, and the
plot of RMSD (in a˚ngstrom) of the complex was shown in
Fig. 5B. HSAF adopted a compact conformation to bind inside
the pocket of b-tubulin (Fig. 5C). The dodecahydrocyclopenta[a]
indene scaffold of HSAF tted into the hydrophobic domain of
b-tubulin, surround by residues Leu215, Lue228 and Leu273.
Importantly, 7-carbonyl group and 27-carbonyl group of HSAF
formed hydrogen bond interactions with residues Met276 and
Ser280, respectively (Fig. 5C).
Taken together, our molecular simulation allowed us to
rationalize the activity prole of the HSAF against b-tubulin,
which provided valuable information for further design of novel
effective b-tubulin inhibitors.
HSAF inhibited C. albicans in vivo
In order to relate the in vitro cytotoxicity with in vivo effects,
a number of toxicity experiments were performed on a murine
model of disseminated infection due to C. albicans with an
Fig. 6 Macroscopic inflammation of kidney taken from mice infected with C. albicans SC5314, the mice were infected by injection of a 100 mL
inoculum containing 1 106 cells ofC. albicans SC5314 via the lateral tail vein. After 3 days’ treatment, mice from each group were euthanized, and
the kidneys were excised for naked eye observations (A). The kidney burden analysis of infected mice receiving indicated treatments (B). Survival
curve of BALB/cmice infected byC. albicans SC5314 (C). Pathology of kidney taken frommice infectedwithC. albicans SC5314. The kidneys ofmice
were excised from the infected model group with no treatment (1), and the groups treated with DMSO (2), AMB (3), FLU (4) and HSAF (5) on the 3rd
days of infection. The images of hematoxylin–eosin (D) or periodic-acid schiff (E) stained sections are presented at 200magnification, bar¼ 3 mm.
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inoculum of 1  106 cells per mouse. HSAF exhibited good
antifungal activity in vivo. It was observed that a signicant
reduction in the virulence of kidney tissue of experimental mice
compared to vehicle (Fig. 6A and B). The effect of HSAF on the
survival of experimental mice infected with C. albicans was
carried out. A signicant increase in the mice treated with HSAF
(26 days) compared to vehicle mice (14 days) and mice treated
with AMB (22 days) and FLU (24 days) was observed (Fig. 6C).
Microscopic examination of kidney sections showed numbers
of pyogranulomatous inammatory foci in the vehicles, while
HSAF treatment reduced the lesions of organ tissue (Fig. 6D and
E). The results showed that HSAF signicantly decreased the
fungal burdens in the kidneys of mice and also tended to
prolong the survival of the infected animals.
Discussion
C. albicans is a common opportunistic fungal pathogen of
humans. Disseminated invasive candidiasis has an estimated
mortality rate of 40%, even with the use of antifungal drugs due
to its toxicity, high price and drug resistance.35 Therefore, the
development of effective antifungal agents and therapies is
urgently needed. Recently, ROS has been focused on, due to
their pivotal role in the apoptosis of many different cell types.
Previous studies have shown that several stimuli, such as acetic
acid,36 resveratrol,37 farsenol38 and antimicrobial peptides39
caused C. albicans cells to undergo apoptosis through ROS
dependent pathway. ROS accumulation is considered to be
a typical hallmark of apoptosis. These previous reports
prompted us to determine whether HSAF induced the apoptosis
through ROS dependent pathway.
In this study, the transcriptional sequencing and analysis
treating with DMSO and HSAF using IIlumina 2000 assembly
technology and RNA-seq quantication analysis were per-
formed. Downstream events, measured by high-content
imaging, and ow cytometry, showed a dramatic increase in
mitochondrially produced ROS and subsequent DNA damage
with up regulation of related proteins. Based on transcriptional
sequencing and analysis, the important regulatory genes
involved in the ROS and apoptosis pathway were identied.
These results will be helpful for illuminating themechanisms of
HSAF on the fungi. To examine the role of HSAF induced ROS in
fungal cell death, ROS production was blocked by adding anti-
oxidants to HSAF-treated cultures. The addition of antioxidants
increased the survival of cultures treated with HSAF, indicating
that HSAF caused ROS-induced fungal cell death. Antioxidant
enhancements protect cells treated with HSAF against
apoptosis, indicating that ROS were not a meaningless side
effect of mitochondrial disintegration but a key regulator to
yeast apoptosis. HSAF belongs to PTMs, which is distinct from
any existing fungicides. To our knowledge, this is the rst study
of PTMs causing apoptosis through ROS dependent apoptotic
pathway in C. albicans.
In conclusion, HSAF, a natural product, induced apoptosis
in C. albicans through ROS dependent pathway. We also found
that HSAF inhibited tubulin polymerization in vitro. The MD
studies revealed that b-tubulinmaybe the target of HSAF against
C. albicans, but it need to be conrmed in future study. Never-
theless, HSAF could be considered as a potential lead in the
development of a novel class of antifungal agents. It shed light
on possible medical applications involving HSAF in particular
for the treatment of C. albicans infections.
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